Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteoporosis R&D legislation

This article was originally published in The Tan Sheet

Executive Summary

Rep. Edward Markey (D-Mass.) introduces the Osteoporosis Risk Reduction Act of 1994 (HR 4284) on April 21 to require FDA to review the relationship between calcium intake and bone mass and osteoporosis. The bill would ask FDA to set optimum calcium intake levels, determine how many Americans consume too little calcium, and provide guidelines for fortifying of grain products with calcium
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082732

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel